Enzyme-linked immunospot assay (ELISPOT) is a highly sensitive technique used to detect and quantify individual cytokine-secreting cells at the single-cell level. This method is essential for immune monitoring in vaccine development, cancer immunotherapy, and infectious disease research. By offering superior sensitivity compared to traditional ELISA, ELISPOT provides critical insights into cellular immune responses.
Technical Overview
The Enzyme-Linked Immunospot (ELISPOT) assay is a widely used immunological assay designed to visualize the secretory activity of individual cells. Originally developed from ELISA principles, this technique allows researchers to enumerate specific cells that secrete particular substances, most commonly cytokines, chemokines, or antibodies. The high sensitivity of ELISPOT enables the detection of rare events, such as antigen-specific T-cell responses, even when the frequency of responding cells is very low. The result is typically presented as spots, where each spot corresponds to a single secreting cell.
Testing Samples
ELISPOT assays are versatile and can be performed on various biological samples containing immune cells. Proper sample handling is critical to maintain cell viability and functionality.
Peripheral Blood Mononuclear Cells (PBMCs)
PBMCs are the most common sample type for human and clinical studies. They are isolated from whole blood via density gradient centrifugation. These cells contain lymphocytes (T cells, B cells, NK cells) and monocytes, making them ideal for monitoring systemic immune responses.
Splenocytes
In preclinical research involving animal models, such as mice or rats, splenocytes are frequently used. The spleen is a rich source of immune cells, and isolating splenocytes allows for the evaluation of immune responses in specific disease models or after vaccination.
Other Cell Populations
Other samples include lymph node cells, bone marrow-derived cells, or purified specific cell subsets like CD4+ or CD8+ T cells. Isolating specific subsets can help define the precise cellular source of the cytokine secretion.
Testing Items
The choice of testing items depends on the specific immune response being investigated. The assay typically targets key signaling molecules involved in immune regulation and effector functions.
- Interferon-gamma (IFN-γ): Often used as a marker for Th1-type immune responses and antigen-specific T-cell activation.
- Interleukin-2 (IL-2): A growth factor for T cells, indicative of T-cell proliferation and helper function.
- Tumor Necrosis Factor-alpha (TNF-α): A pro-inflammatory cytokine involved in systemic inflammation and immune defense.
- Interleukin-4 (IL-4), IL-5, IL-13: These are markers for Th2-type responses, typically associated with allergy and antibody production.
- Interleukin-17 (IL-17): A marker for Th17 cells, playing a role in autoimmune diseases and extracellular pathogen defense.
- Granzyme B and Perforin: Molecules released by cytotoxic T lymphocytes (CTLs) and NK cells to induce target cell death.
Testing Methods
The ELISPOT procedure follows a structured workflow to ensure accurate capture and detection of secreted analytes. Adherence to protocol is vital for minimizing background noise and maximizing spot clarity.
Coating and Blocking
The assay begins with a high-binding PVDF or nitrocellulose membrane plate. Capture antibodies specific to the target cytokine are coated onto the membrane. After incubation, the plate is blocked with a protein-rich medium to prevent non-specific binding, which reduces background noise.
Cell Incubation
Cells are seeded into the wells and stimulated with specific antigens, mitogens, or controls. During the incubation period (typically 24 to 48 hours), stimulated cells secrete the target cytokine. The secreted cytokine is captured immediately by the membrane-bound antibodies surrounding the cell.
Detection and Enumeration
Following incubation, cells are removed, and a biotinylated detection antibody is added, followed by an enzyme-streptavidin conjugate. Finally, a precipitating substrate is added, producing a colored spot at the site of cytokine capture. These spots are counted using an automated ELISPOT reader, and the results are reported as Spot Forming Units (SFU) per million cells.
Applications
Due to its sensitivity and quantitative nature, ELISPOT is a cornerstone technique in both basic immunology and clinical trials.
Vaccine Development
ELISPOT is the gold standard for evaluating T-cell immunogenicity in vaccine candidates. It helps researchers determine if a vaccine successfully elicits a T-cell response against specific pathogens or tumor antigens.
Cancer Immunotherapy
In the field of onco-immunology, the assay is used to monitor the efficacy of immune checkpoint inhibitors or CAR-T therapies. By measuring antigen-specific T cells, clinicians can assess the immune system's engagement with the tumor.
Infectious Disease Research
Researchers utilize ELISPOT to study host responses to viruses like HIV, Hepatitis B, and SARS-CoV-2. It aids in mapping the immune correlates of protection and understanding disease pathogenesis.
Transplantation Immunology
The assay can detect donor-reactive T cells in transplant recipients, helping to predict the risk of graft rejection or graft-versus-host disease (GVHD).
FAQ
What is the difference between ELISA and ELISPOT?
ELISA measures the total concentration of a soluble cytokine in the supernatant, providing a bulk average. ELISPOT, conversely, detects the actual number of cells secreting the cytokine, offering single-cell resolution. ELISPOT is generally considered more sensitive for detecting low-frequency secreting cells.
How should samples be prepared for ELISPOT?
Cell viability is the most critical factor for successful ELISPOT results. Samples like PBMCs should be processed quickly, cryopreserved properly using controlled-rate freezing, and thawed carefully to maximize viability. High viability (usually over 80-90%) is required to ensure that the lack of spots is due to a lack of response rather than cell death.
Can ELISPOT detect multiple cytokines simultaneously?
Yes, dual-color or multiplex ELISPOT assays are available. These utilize different enzymatic substrates (e.g., BCIP/NBT and AEC) to produce distinctively colored spots, allowing for the simultaneous detection of two cytokines secreted by the same or different cell populations.